Global Cephalosporin Drugs Market Analysis & Trends - Industry Forecast to 2027

  • ID: 4463116
  • Report
  • Region: Global
  • 159 pages
  • Accuray Research LLP
1 of 4

FEATURED COMPANIES

  • Abbott
  • Aspen Pharmacare
  • Basilea Pharmaceuticals
  • Bristol-Myers Squibb
  • Kyorin Pharmaceutical
  • Merck
  • MORE
The Global Cephalosporin Drugs Market is poised for strong growth during the forecast period 2017 to 2027. Some of the prominent trends that the market is witnessing include rising incidence of diseases, growing research & development activities and increasing healthcare awareness.

Based on cable type, market is segmented into generics and branded. Depending on route of administration, market is divided into Injectables and Oral. On the basis of Spectrum, market is classified into fifth generation, fourth generation, third generation, second generation and first generation.

Based on type of treatment, market is segmented into first line of treatment and second line of treatment. First Line of Treatment segment is further classified into serious infections and sexually transmitted infections. Second Line of Treatment segment is further classified into urinary tract infections in pregnancy, respiratory tract infections and skin infections.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

This report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:

North America
  • US
  • Canada
  • Mexico
Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • New Zealand
  • Rest of Asia Pacific
Middle East
  • Saudi Arabia
  • UAE
  • Rest of Middle East
Latin America
  • Argentina
  • Brazil
  • Rest of Latin America
Rest of the World
  • South Africa
  • Others
Report Highlights:
  • The report provides a detailed analysis on current and future market trends to identify the investment opportunities
  • Market forecasts till 2027, using estimated market values as the base numbers
  • Key market trends across the business segments, Regions and Countries
  • Key developments and strategies observed in the market
  • Market Dynamics such as Drivers, Restraints, Opportunities and other trends
  • In-depth company profiles of key players and upcoming prominent players
  • Growth prospects among the emerging nations through 2027
  • Market opportunities and recommendations for new investments
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • Aspen Pharmacare
  • Basilea Pharmaceuticals
  • Bristol-Myers Squibb
  • Kyorin Pharmaceutical
  • Merck
  • MORE
1 Market Outline
1.1 Research Methodology
1.1.1 Research Approach & Sources
1.2 Market Trends
1.3 Regulatory Factors
1.4 Product Analysis
1.5 Strategic Benchmarking
1.6 Opportunity Analysis

2 Executive Summary

3 Market Overview
3.1 Current Trends
3.1.1 Raising incidence of diseases
3.1.2 Growing research & development activities
3.1.3 Increasing healthcare awareness
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
3.4.1 Bargaining power of suppliers
3.4.2 Bargaining power of buyers
3.4.3 Threat of substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry

4 Cephalosporin Drugs Market, By Cable Type
4.1 Generics
4.1.1 Generics Market Forecast to 2027 (US$ MN)
4.2 Branded
4.2.1 Branded Market Forecast to 2027 (US$ MN)

5 Cephalosporin Drugs Market, By Route of Administration
5.1 Injectables
5.1.1 Injectables Market Forecast to 2027 (US$ MN)
5.2 Oral
5.2.1 Oral Market Forecast to 2027 (US$ MN)

6 Cephalosporin Drugs Market, By Spectrum
6.1 Fifth Generation
6.1.1 Fifth Generation Market Forecast to 2027 (US$ MN)
6.2 Fourth Generation
6.2.1 Fourth Generation Market Forecast to 2027 (US$ MN)
6.3 Third Generation
6.3.1 Third Generation Market Forecast to 2027 (US$ MN)
6.4 Second Generation
6.4.1 Second Generation Market Forecast to 2027 (US$ MN)
6.5 First Generation
6.5.1 First Generation Market Forecast to 2027 (US$ MN)

7 Cephalosporin Drugs Market, By Type of Treatment
7.1 First Line of Treatment
7.1.1 First Line of Treatment Market Forecast to 2027 (US$ MN)
7.1.1.1 Serious infections
7.1.1.1.1 Serious infections Market Forecast to 2027 (US$ MN)
7.1.1.1.1.1 Meningitis
7.1.1.1.1.1.1 Meningitis Market Forecast to 2027 (US$ MN)
7.1.1.2 Sexually transmitted infections
7.1.1.2.1 Sexually transmitted infections Market Forecast to 2027 (US$ MN)
7.1.1.2.1.1 Pelvic inflammatory disease
7.1.1.2.1.1.1 Pelvic inflammatory disease Market Forecast to 2027 (US$ MN)
7.1.1.2.1.2 Gonorrhoea
7.1.1.2.1.2.1 Gonorrhoea Market Forecast to 2027 (US$ MN)
7.1.1.2.1.3 Epididymo-orchitis
7.1.1.2.1.3.1 Epididymo-orchitis Market Forecast to 2027 (US$ MN)
7.2 Second Line of Treatment
7.2.1 Second Line of Treatment Market Forecast to 2027 (US$ MN)
7.2.1.1 Urinary tract infections in pregnancy
7.2.1.1.1 Urinary tract infections in pregnancy Market Forecast to 2027 (US$ MN)
7.2.1.2 Respiratory tract infections
7.2.1.2.1 Respiratory tract infections Market Forecast to 2027 (US$ MN)
7.2.1.2.1.1 Sinusitis
7.2.1.2.1.1.1 Sinusitis Market Forecast to 2027 (US$ MN)
7.2.1.2.1.2 Otitis media
7.2.1.2.1.2.1 Otitis media Market Forecast to 2027 (US$ MN)
7.2.1.3 Skin infections
7.2.1.3.1 Skin infections Market Forecast to 2027 (US$ MN)
7.2.1.3.1.1 Mastitis
7.2.1.3.1.1.1 Mastitis Market Forecast to 2027 (US$ MN)
7.2.1.3.1.2 Diabetic foot infections
7.2.1.3.1.2.1 Diabetic foot infections Market Forecast to 2027 (US$ MN)
7.2.1.3.1.3 Cellulitis
7.2.1.3.1.3.1 Cellulitis Market Forecast to 2027 (US$ MN)

8 Cephalosporin Drugs Market, By Geography
8.1 North America
8.1.1 North America Market Forecast by Countries to 2027 (US$ MN)
8.1.1.1 US
8.1.1.2 Canada
8.1.1.3 Mexico
8.2 Europe
8.2.1 Europe Market Forecast by Countries to 2027 (US$ MN)
8.2.1.1 Germany
8.2.1.2 U.K.
8.2.1.3 Italy
8.2.1.4 France
8.2.1.5 Spain
8.2.1.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Asia Pacific Market Forecast by Countries to 2027 (US$ MN)
8.3.1.1 China
8.3.1.2 Japan
8.3.1.3 India
8.3.1.4 Australia
8.3.1.5 New Zealand
8.3.1.6 Rest of APAC
8.4 Middle East
8.4.1 Middle East Market Forecast by Countries to 2027 (US$ MN)
8.4.1.1 Saudi Arabia
8.4.1.2 UAE
8.4.1.3 Rest of Middle East
8.5 Latin America
8.5.1 Latin America Market Forecast by Countries to 2027 (US$ MN)
8.5.1.1 Argentina
8.5.1.2 Brazil
8.5.1.3 Rest of Latin America
8.6 Rest of the World (RoW)
8.6.1 RoW Market Forecast by Countries to 2027 (US$ MN)
8.6.1.1 South Africa
8.6.1.2 Others

9 Key Player Activities
9.1 Mergers & Acquisitions
9.2 Partnerships, Joint Venture’s, Collaborations and Agreements
9.3 Product Launch & Expansions
9.4 Other Activities

10 Leading Companies
10.1 Abbott
10.2 Allergan
10.3 Aspen Pharmacare
10.4 Astellas
10.5 Basilea Pharmaceuticals
10.6 Baxter
10.7 Bristol-Myers Squibb
10.8 Glaxo SmithKline
10.9 Kyorin Pharmaceutical
10.10 Lupin Pharmaceuticals
10.11 Merck
10.12 Pfizer
10.13 Ranbaxy
10.14 Roche
10.15 Sandoz
10.16 Teva Pharmaceuticals

List of Tables
Table 1 Global Cephalosporin Drugs Market By Region, Market Forecast (2015-2027) (US $MN)
Table 2 Global Cephalosporin Drugs Market By Type, Market Forecast (2015-2027) (US $MN)
Table 3 Global Cephalosporin Drugs Market By Generics, Market Forecast (2015-2027) (US $MN)
Table 4 Global Cephalosporin Drugs Market By Branded, Market Forecast (2015-2027) (US $MN)
Table 5 Global Cephalosporin Drugs Market By Route of Administration, Market Forecast (2015-2027) (US $MN)
Table 6 Global Cephalosporin Drugs Market By Injectables, Market Forecast (2015-2027) (US $MN)
Table 7 Global Cephalosporin Drugs Market By Oral, Market Forecast (2015-2027) (US $MN)
Table 8 Global Cephalosporin Drugs Market By Spectrum, Market Forecast (2015-2027) (US $MN)
Table 9 Global Cephalosporin Drugs Market By Fifth Generation, Market Forecast (2015-2027) (US $MN)
Table 10 Global Cephalosporin Drugs Market By Fourth Generation, Market Forecast (2015-2027) (US $MN)
Table 11 Global Cephalosporin Drugs Market By Third Generation, Market Forecast (2015-2027) (US $MN)
Table 12 Global Cephalosporin Drugs Market By Second Generation, Market Forecast (2015-2027) (US $MN)
Table 13 Global Cephalosporin Drugs Market By First Generation, Market Forecast (2015-2027) (US $MN)
Table 14 Global Cephalosporin Drugs Market By Type of Treatment, Market Forecast (2015-2027) (US $MN)
Table 15 Global Cephalosporin Drugs Market By First Line of Treatment, Market Forecast (2015-2027) (US $MN)
Table 16 Global Cephalosporin Drugs Market By Serious infections, Market Forecast (2015-2027) (US $MN)
Table 17 Global Cephalosporin Drugs Market By Sexually transmitted infections, Market Forecast (2015-2027) (US $MN)
Table 18 Global Cephalosporin Drugs Market By Second Line of Treatment, Market Forecast (2015-2027) (US $MN)
Table 19 Global Cephalosporin Drugs Market By Urinary tract infections in pregnancy, Market Forecast (2015-2027) (US $MN)
Table 20 Global Cephalosporin Drugs Market By Respiratory tract infections, Market Forecast (2015-2027) (US $MN)
Table 21 Global Cephalosporin Drugs Market By Skin infections, Market Forecast (2015-2027) (US $MN)
Table 22 North America Cephalosporin Drugs Market By Country, Market Forecast (2015-2027) (US $MN)
Table 23 North America Cephalosporin Drugs Market By Type, Market Forecast (2015-2027) (US $MN)
Table 24 North America Cephalosporin Drugs Market By Generics, Market Forecast (2015-2027) (US $MN)
Table 25 North America Cephalosporin Drugs Market By Branded, Market Forecast (2015-2027) (US $MN)
Table 26 North America Cephalosporin Drugs Market By Route of Administration, Market Forecast (2015-2027) (US $MN)
Table 27 North America Cephalosporin Drugs Market By Injectables, Market Forecast (2015-2027) (US $MN)
Table 28 North America Cephalosporin Drugs Market By Oral, Market Forecast (2015-2027) (US $MN)
Table 29 North America Cephalosporin Drugs Market By Spectrum, Market Forecast (2015-2027) (US $MN)
Table 30 North America Cephalosporin Drugs Market By Fifth Generation, Market Forecast (2015-2027) (US $MN)
Table 31 North America Cephalosporin Drugs Market By Fourth Generation, Market Forecast (2015-2027) (US $MN)
Table 32 North America Cephalosporin Drugs Market By Third Generation, Market Forecast (2015-2027) (US $MN)
Table 33 North America Cephalosporin Drugs Market By Second Generation, Market Forecast (2015-2027) (US $MN)
Table 34 North America Cephalosporin Drugs Market By First Generation, Market Forecast (2015-2027) (US $MN)
Table 35 North America Cephalosporin Drugs Market By Type of Treatment, Market Forecast (2015-2027) (US $MN)
Table 36 North America Cephalosporin Drugs Market By First Line of Treatment, Market Forecast (2015-2027) (US $MN)
Table 37 North America Cephalosporin Drugs Market By Serious infections, Market Forecast (2015-2027) (US $MN)
Table 38 North America Cephalosporin Drugs Market By Sexually transmitted infections, Market Forecast (2015-2027) (US $MN)
Table 39 North America Cephalosporin Drugs Market By Second Line of Treatment, Market Forecast (2015-2027) (US $MN)
Table 40 North America Cephalosporin Drugs Market By Urinary tract infections in pregnancy, Market Forecast (2015-2027) (US $MN)
Table 41 North America Cephalosporin Drugs Market By Respiratory tract infections, Market Forecast (2015-2027) (US $MN)
Table 42 North America Cephalosporin Drugs Market By Skin infections, Market Forecast (2015-2027) (US $MN)
Table 43 Europe Cephalosporin Drugs Market By Country, Market Forecast (2015-2027) (US $MN)
Table 44 Europe Cephalosporin Drugs Market By Type, Market Forecast (2015-2027) (US $MN)
Table 45 Europe Cephalosporin Drugs Market By Generics, Market Forecast (2015-2027) (US $MN)
Table 46 Europe Cephalosporin Drugs Market By Branded, Market Forecast (2015-2027) (US $MN)
Table 47 Europe Cephalosporin Drugs Market By Route of Administration, Market Forecast (2015-2027) (US $MN)
Table 48 Europe Cephalosporin Drugs Market By Injectables, Market Forecast (2015-2027) (US $MN)
Table 49 Europe Cephalosporin Drugs Market By Oral, Market Forecast (2015-2027) (US $MN)
Table 50 Europe Cephalosporin Drugs Market By Spectrum, Market Forecast (2015-2027) (US $MN)
Table 51 Europe Cephalosporin Drugs Market By Fifth Generation, Market Forecast (2015-2027) (US $MN)
Table 52 Europe Cephalosporin Drugs Market By Fourth Generation, Market Forecast (2015-2027) (US $MN)
Table 53 Europe Cephalosporin Drugs Market By Third Generation, Market Forecast (2015-2027) (US $MN)
Table 54 Europe Cephalosporin Drugs Market By Second Generation, Market Forecast (2015-2027) (US $MN)
Table 55 Europe Cephalosporin Drugs Market By First Generation, Market Forecast (2015-2027) (US $MN)
Table 56 Europe Cephalosporin Drugs Market By Type of Treatment, Market Forecast (2015-2027) (US $MN)
Table 57 Europe Cephalosporin Drugs Market By First Line of Treatment, Market Forecast (2015-2027) (US $MN)
Table 58 Europe Cephalosporin Drugs Market By Serious infections, Market Forecast (2015-2027) (US $MN)
Table 59 Europe Cephalosporin Drugs Market By Sexually transmitted infections, Market Forecast (2015-2027) (US $MN)
Table 60 Europe Cephalosporin Drugs Market By Second Line of Treatment, Market Forecast (2015-2027) (US $MN)
Table 61 Europe Cephalosporin Drugs Market By Urinary tract infections in pregnancy, Market Forecast (2015-2027) (US $MN)
Table 62 Europe Cephalosporin Drugs Market By Respiratory tract infections, Market Forecast (2015-2027) (US $MN)
Table 63 Europe Cephalosporin Drugs Market By Skin infections, Market Forecast (2015-2027) (US $MN)
Table 64 Asia Pacific Cephalosporin Drugs Market By Country, Market Forecast (2015-2027) (US $MN)
Table 65 Asia Pacific Cephalosporin Drugs Market By Type, Market Forecast (2015-2027) (US $MN)
Table 66 Asia Pacific Cephalosporin Drugs Market By Generics, Market Forecast (2015-2027) (US $MN)
Table 67 Asia Pacific Cephalosporin Drugs Market By Branded, Market Forecast (2015-2027) (US $MN)
Table 68 Asia Pacific Cephalosporin Drugs Market By Route of Administration, Market Forecast (2015-2027) (US $MN)
Table 69 Asia Pacific Cephalosporin Drugs Market By Injectables, Market Forecast (2015-2027) (US $MN)
Table 70 Asia Pacific Cephalosporin Drugs Market By Oral, Market Forecast (2015-2027) (US $MN)
Table 71 Asia Pacific Cephalosporin Drugs Market By Spectrum, Market Forecast (2015-2027) (US $MN)
Table 72 Asia Pacific Cephalosporin Drugs Market By Fifth Generation, Market Forecast (2015-2027) (US $MN)
Table 73 Asia Pacific Cephalosporin Drugs Market By Fourth Generation, Market Forecast (2015-2027) (US $MN)
Table 74 Asia Pacific Cephalosporin Drugs Market By Third Generation, Market Forecast (2015-2027) (US $MN)
Table 75 Asia Pacific Cephalosporin Drugs Market By Second Generation, Market Forecast (2015-2027) (US $MN)
Table 76 Asia Pacific Cephalosporin Drugs Market By First Generation, Market Forecast (2015-2027) (US $MN)
Table 77 Asia Pacific Cephalosporin Drugs Market By Type of Treatment, Market Forecast (2015-2027) (US $MN)
Table 78 Asia Pacific Cephalosporin Drugs Market By First Line of Treatment, Market Forecast (2015-2027) (US $MN)
Table 79 Asia Pacific Cephalosporin Drugs Market By Serious infections, Market Forecast (2015-2027) (US $MN)
Table 80 Asia Pacific Cephalosporin Drugs Market By Sexually transmitted infections, Market Forecast (2015-2027) (US $MN)
Table 81 Asia Pacific Cephalosporin Drugs Market By Second Line of Treatment, Market Forecast (2015-2027) (US $MN)
Table 82 Asia Pacific Cephalosporin Drugs Market By Urinary tract infections in pregnancy, Market Forecast (2015-2027) (US $MN)
Table 83 Asia Pacific Cephalosporin Drugs Market By Respiratory tract infections, Market Forecast (2015-2027) (US $MN)
Table 84 Asia Pacific Cephalosporin Drugs Market By Skin infections, Market Forecast (2015-2027) (US $MN)
Table 85 Middle East Cephalosporin Drugs Market By Country, Market Forecast (2015-2027) (US $MN)
Table 86 Middle East Cephalosporin Drugs Market By Type, Market Forecast (2015-2027) (US $MN)
Table 87 Middle East Cephalosporin Drugs Market By Generics, Market Forecast (2015-2027) (US $MN)
Table 88 Middle East Cephalosporin Drugs Market By Branded, Market Forecast (2015-2027) (US $MN)
Table 89 Middle East Cephalosporin Drugs Market By Route of Administration, Market Forecast (2015-2027) (US $MN)
Table 90 Middle East Cephalosporin Drugs Market By Injectables, Market Forecast (2015-2027) (US $MN)
Table 91 Middle East Cephalosporin Drugs Market By Oral, Market Forecast (2015-2027) (US $MN)
Table 92 Middle East Cephalosporin Drugs Market By Spectrum, Market Forecast (2015-2027) (US $MN)
Table 93 Middle East Cephalosporin Drugs Market By Fifth Generation, Market Forecast (2015-2027) (US $MN)
Table 94 Middle East Cephalosporin Drugs Market By Fourth Generation, Market Forecast (2015-2027) (US $MN)
Table 95 Middle East Cephalosporin Drugs Market By Third Generation, Market Forecast (2015-2027) (US $MN)
Table 96 Middle East Cephalosporin Drugs Market By Second Generation, Market Forecast (2015-2027) (US $MN)
Table 97 Middle East Cephalosporin Drugs Market By First Generation, Market Forecast (2015-2027) (US $MN)
Table 98 Middle East Cephalosporin Drugs Market By Type of Treatment, Market Forecast (2015-2027) (US $MN)
Table 99 Middle East Cephalosporin Drugs Market By First Line of Treatment, Market Forecast (2015-2027) (US $MN)
Table 100 Middle East Cephalosporin Drugs Market By Serious infections, Market Forecast (2015-2027) (US $MN)
Table 101 Middle East Cephalosporin Drugs Market By Sexually transmitted infections, Market Forecast (2015-2027) (US $MN)
Table 102 Middle East Cephalosporin Drugs Market By Second Line of Treatment, Market Forecast (2015-2027) (US $MN)
Table 103 Middle East Cephalosporin Drugs Market By Urinary tract infections in pregnancy, Market Forecast (2015-2027) (US $MN)
Table 104 Middle East Cephalosporin Drugs Market By Respiratory tract infections, Market Forecast (2015-2027) (US $MN)
Table 105 Middle East Cephalosporin Drugs Market By Skin infections, Market Forecast (2015-2027) (US $MN)
Table 106 Latin America Cephalosporin Drugs Market By Country, Market Forecast (2015-2027) (US $MN)
Table 107 Latin America Cephalosporin Drugs Market By Type, Market Forecast (2015-2027) (US $MN)
Table 108 Latin America Cephalosporin Drugs Market By Generics, Market Forecast (2015-2027) (US $MN)
Table 109 Latin America Cephalosporin Drugs Market By Branded, Market Forecast (2015-2027) (US $MN)
Table 110 Latin America Cephalosporin Drugs Market By Route of Administration, Market Forecast (2015-2027) (US $MN)
Table 111 Latin America Cephalosporin Drugs Market By Injectables, Market Forecast (2015-2027) (US $MN)
Table 112 Latin America Cephalosporin Drugs Market By Oral, Market Forecast (2015-2027) (US $MN)
Table 113 Latin America Cephalosporin Drugs Market By Spectrum, Market Forecast (2015-2027) (US $MN)
Table 114 Latin America Cephalosporin Drugs Market By Fifth Generation, Market Forecast (2015-2027) (US $MN)
Table 115 Latin America Cephalosporin Drugs Market By Fourth Generation, Market Forecast (2015-2027) (US $MN)
Table 116 Latin America Cephalosporin Drugs Market By Third Generation, Market Forecast (2015-2027) (US $MN)
Table 117 Latin America Cephalosporin Drugs Market By Second Generation, Market Forecast (2015-2027) (US $MN)
Table 118 Latin America Cephalosporin Drugs Market By First Generation, Market Forecast (2015-2027) (US $MN)
Table 119 Latin America Cephalosporin Drugs Market By Type of Treatment, Market Forecast (2015-2027) (US $MN)
Table 120 Latin America Cephalosporin Drugs Market By First Line of Treatment, Market Forecast (2015-2027) (US $MN)
Table 121 Latin America Cephalosporin Drugs Market By Serious infections, Market Forecast (2015-2027) (US $MN)
Table 122 Latin America Cephalosporin Drugs Market By Sexually transmitted infections, Market Forecast (2015-2027) (US $MN)
Table 123 Latin America Cephalosporin Drugs Market By Second Line of Treatment, Market Forecast (2015-2027) (US $MN)
Table 124 Latin America Cephalosporin Drugs Market By Urinary tract infections in pregnancy, Market Forecast (2015-2027) (US $MN)
Table 125 Latin America Cephalosporin Drugs Market By Respiratory tract infections, Market Forecast (2015-2027) (US $MN)
Table 126 Latin America Cephalosporin Drugs Market By Skin infections, Market Forecast (2015-2027) (US $MN)
Table 127 RoW Cephalosporin Drugs Market By Country, Market Forecast (2015-2027) (US $MN)
Table 128 RoW Cephalosporin Drugs Market By Type, Market Forecast (2015-2027) (US $MN)
Table 129 RoW Cephalosporin Drugs Market By Generics, Market Forecast (2015-2027) (US $MN)
Table 130 RoW Cephalosporin Drugs Market By Branded, Market Forecast (2015-2027) (US $MN)
Table 131 RoW Cephalosporin Drugs Market By Route of Administration, Market Forecast (2015-2027) (US $MN)
Table 132 RoW Cephalosporin Drugs Market By Injectables, Market Forecast (2015-2027) (US $MN)
Table 133 RoW Cephalosporin Drugs Market By Oral, Market Forecast (2015-2027) (US $MN)
Table 134 RoW Cephalosporin Drugs Market By Spectrum, Market Forecast (2015-2027) (US $MN)
Table 135 RoW Cephalosporin Drugs Market By Fifth Generation, Market Forecast (2015-2027) (US $MN)
Table 136 RoW Cephalosporin Drugs Market By Fourth Generation, Market Forecast (2015-2027) (US $MN)
Table 137 RoW Cephalosporin Drugs Market By Third Generation, Market Forecast (2015-2027) (US $MN)
Table 138 RoW Cephalosporin Drugs Market By Second Generation, Market Forecast (2015-2027) (US $MN)
Table 139 RoW Cephalosporin Drugs Market By First Generation, Market Forecast (2015-2027) (US $MN)
Table 140 RoW Cephalosporin Drugs Market By Type of Treatment, Market Forecast (2015-2027) (US $MN)
Table 141 RoW Cephalosporin Drugs Market By First Line of Treatment, Market Forecast (2015-2027) (US $MN)
Table 142 RoW Cephalosporin Drugs Market By Serious infections, Market Forecast (2015-2027) (US $MN)
Table 143 RoW Cephalosporin Drugs Market By Sexually transmitted infections, Market Forecast (2015-2027) (US $MN)
Table 144 RoW Cephalosporin Drugs Market By Second Line of Treatment, Market Forecast (2015-2027) (US $MN)
Table 145 RoW Cephalosporin Drugs Market By Urinary tract infections in pregnancy, Market Forecast (2015-2027) (US $MN)
Table 146 RoW Cephalosporin Drugs Market By Respiratory tract infections, Market Forecast (2015-2027) (US $MN)
Table 147 RoW Cephalosporin Drugs Market By Skin infections, Market Forecast (2015-2027) (US $MN)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott
  • Allergan
  • Aspen Pharmacare
  • Astellas
  • Basilea Pharmaceuticals
  • Baxter
  • Bristol-Myers Squibb
  • Glaxo SmithKline
  • Kyorin Pharmaceutical
  • Lupin Pharmaceuticals
  • Merck
  • Pfizer
  • Ranbaxy
  • Roche
  • Sandoz
  • Teva Pharmaceuticals
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll